Todd Brady

Chief Executive Officer, President & Director at Aldeyra Therapeutics, Inc.

Todd Brady

Todd Brady

Chief Executive Officer, President & Director at Aldeyra Therapeutics, Inc.

Overview
Career Highlights

Aldeyra Therapeutics, Inc.
Phenome Sciences, Inc.

RelSci Relationships

421

Number of Boards

20

Birthday

1972

Age

49

Contact Data
Trying to get in touch with Todd Brady? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Todd Brady likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Domain Associates LLC

Relationship likelihood: Strong

Managing Member at One Palmer Square Associates VIII LLC

Relationship likelihood: Strong

Co-Founder at Aclaris Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Evoke Pharma, Inc.

Relationship likelihood: Strong

Founder at Kanisa Pharmaceuticals, Inc.

Relationship likelihood: Strong

Executive Officer at Ascendance Biotechnology, Inc.

Relationship likelihood: Strong

Former Executive Chairman at Envisia Therapeutics, Inc.

Relationship likelihood: Strong

Executive Chairman at Kalyra Pharmaceuticals, Inc.

Relationship likelihood: Strong

Executive Chairman at FluGen, Inc.

Relationship likelihood: Strong

Vice President, Venture Investments at Johnson & Johnson Innovation JJDC, Inc.

Relationship likelihood: Strong

Paths to Todd Brady
Potential Connections via
Relationship Science
You
Todd Brady
Chief Executive Officer, President & Director at Aldeyra Therapeutics, Inc.
Education
MD
Class of 1999

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

MD
Class of 1999

Duke Medicine conceptually integrates the Duke University Health System, the Duke University School of Medicine, and the Duke University School of Nursing. It is the combination of research, clinical care, and education that takes place through the efforts of our faculty, staff, students, and trainees at many different sites throughout our region and worldwide. In 2006, Duke Medicine adopted new mission and vision statements that describe the overarching goals and shared aspirations of all of its components -- including the Duke University Health System, the Duke University School of Medicine, and the Duke University School of Nursing. We also finalized strategic plans to guide our efforts over the next five to 10 years.

BA Philosophy, Psychology
Class of 1993

Founded in 1769, Dartmouth is a member of the Ivy League and consistently ranks among the world's greatest academic institutions. Dartmouth has forged a singular identity for combining its deep commitment to outstanding undergraduate liberal arts and graduate education with distinguished research and scholarship in the Arts & Sciences and its three leading professional schools—the Geisel School of Medicine, Thayer School of Engineering, and the Tuck School of Business.

Career History
Chief Executive Officer, President & Director
2005 - Current

Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Tenure Unconfirmed

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.

Principal
2004 - Prior

Domain Associates is an active investor invests in early stage transactions. The firm in which they invests include life sciences industry and technologies. They take a seat on the Board of Directors in the vast majority of cases. Most of their investments are in private companies, but they also invest in small-cap public healthcare companies. It makes investments in public companies.

Boards & Committees
Member, Board of Directors
Current

Asmacure Ltée develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases. The company was founded by Yvon Cormier and Evelyne Israel-Assayag in 2002 and is headquartered in Quebec, Canada.

Member, Board of Directors
Current

TO FOSTER THE GROWTH OF THE LIFE SCIENCES INDUSTRY IN THE SOUTHEASTERN UNITED STATES BY PROMOTING ENTREPRENEURSHIP AND BRINGING TOGETHER THE KEY STAKEHOLDERS ACTIVE IN THE DEVELOPMENT OF THE INDUSTRY.

Member, Board of Visitors
Current
Political Donations
$2,000
2009

Former Senator from North Dakota

Transactions
Details Hidden

Aldeyra Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Aldeyra Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Aldeyra Therapeutics, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Todd Brady. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Todd Brady's profile does not indicate a business or promotional relationship of any kind between RelSci and Todd Brady.